FDA recalls over 13,000 bottles of Inventia chlorthalidone tablets
The US Food and Drug Administration announced a voluntary recall on September 3, 2026, involving more than 13,000 bottles of 25 mg chlorthalidone tablets manufactured by Inventia Healthcare Limited.
Failed lab tests trigger action
Inventia Healthcare Limited voluntarily recalled the medication because the tablets failed dissolution specifications. This specific test measures how the medicine is released from the pill. The company initiated this recall after laboratory results showed the products did not meet required standards.
Second recall of the year
This event marks the second time Inventia has recalled these 25 mg tablets in 2026. A previous recall began on June 5 and covered 11,460 bottles with the same expiration date. Together, the two Class II recalls cover a total of 25,027 bottles nationwide.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.